Back to Search Start Over

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus.

Authors :
Romero-Ramírez S
Sosa-Hernández VA
Cervantes-Díaz R
Carrillo-Vázquez DA
Meza-Sánchez DE
Núñez-Álvarez C
Torres-Ruiz J
Gómez-Martín D
Maravillas-Montero JL
Source :
Frontiers in immunology [Front Immunol] 2023 Feb 22; Vol. 14, pp. 1080154. Date of Electronic Publication: 2023 Feb 22 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Immunoglobulin A (IgA) is the main antibody isotype in body fluids such as tears, intestinal mucous, colostrum, and saliva. There are two subtypes of IgA in humans: IgA1, mainly present in blood and mucosal sites, and IgA2, preferentially expressed in mucosal sites like the colon. In clinical practice, immunoglobulins are typically measured in venous or capillary blood; however, alternative samples, including saliva, are now being considered, given their non-invasive and easy collection nature. Several autoimmune diseases have been related to diverse abnormalities in oral mucosal immunity, such as rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus (SLE).<br />Methods: We decided to evaluate the levels of both IgA subtypes in the saliva of SLE patients. A light chain capture-based ELISA measured specific IgA1 and IgA2 levels in a cohort of SLE patients compared with age and gender-matched healthy volunteers.<br />Results: Surprisingly, our results indicated that in the saliva of SLE patients, total IgA and IgA1 subtype were significantly elevated; we also found that salivary IgA levels, particularly IgA2, positively correlate with anti-dsDNA IgG antibody titers. Strikingly, we also detected the presence of salivary anti-nucleosome IgA antibodies in SLE patients, a feature not previously reported elsewhere.<br />Conclusions: According to our results and upon necessary validation, IgA characterization in saliva could represent a potentially helpful tool in the clinical care of SLE patients with the advantage of being a more straightforward, faster, and safer method than manipulating blood samples.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Romero-Ramírez, Sosa-Hernández, Cervantes-Díaz, Carrillo-Vázquez, Meza-Sánchez, Núñez-Álvarez, Torres-Ruiz, Gómez-Martín and Maravillas-Montero.)

Details

Language :
English
ISSN :
1664-3224
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
36911711
Full Text :
https://doi.org/10.3389/fimmu.2023.1080154